Try it
Dermatology · Bacterial infections: topical antibiotics
Sample itemWhat is the mechanism of action of topical mupirocin used for impetigo and nasal carriage of Staphylococcus aureus?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Inhibition of bacterial isoleucyl-tRNA synthetase
Mupirocin competitively inhibits isoleucyl-tRNA synthetase and so halts protein synthesis. Resistance develops with prolonged use, so courses should be limited to about 5 to 10 days.
Option by option
A. Binding to D-Ala-D-Ala to block cell wall synthesis
D-Ala-D-Ala binding describes vancomycin.
B. Binding to the 30S ribosomal subunit
30S binding describes aminoglycosides and tetracyclines.
C. Inhibition of DNA gyrase
DNA gyrase inhibition describes quinolones.
D. Inhibition of bacterial isoleucyl-tRNA synthetase (correct)
Correct. Isoleucyl-tRNA synthetase inhibition is unique to mupirocin.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Dermatology questions
- Blistering disordersA patient has flaccid blisters that rupture easily and a positive Nikolsky sign. Which c…
- LeprosyIn which type of leprosy is the lepromin test strongly positive?
- Pigmentary disordersA man has well-demarcated chalk-white macules on his hands and around his mouth. A skin…
- Drug reactionsWhich of the following drugs is a well-recognised trigger of Stevens–Johnson syndrome an…